Two studies from Denmark [32, 36], using a grace period of 90 days (as was done in our main analyses), reported that approximately 20% of both GLP-1 receptor agonist users [32, 36] and SGLT2 inhibitor users [32] had discontinued treatment within 1 year of treatment initiation
This waiting period is a major topic of discussion because many people want to be sure they are making the safest choice for themselves and their future children
HerSolution may interact with antipsychotics, carbamazepine, estrogen, lithium, SSRIs, triazolam, and valproic acid due to the inclusion of DHEA.7 The DHEA in HerSolution might also worsen psychiatric disorders and increase the risk of mania in those with mood disorders
This promotion applies to all five available dose strengths of Wegovy
Always consult with your healthcare provider for personalized advice and support throughout your treatment